基金经理：过蓓蓓
| 单位净值:1.3741 | 净值增长率:-1.53% | 净值增长率:-1.53% | 累计净值:1.3741 | 截止日期:2026/6/5 | |
|---|---|---|---|---|---|
| 最新估值:-(-) | 涨跌幅:- | 涨跌额:- | |||
| 最新规模:0.01亿元 | 风险等级:高风险 | 申购状态:可申购 | 赎回状态:可赎回 |
展开全部
- 基本资料
- 投资风格
- 基金财务状况
- 基金评级
汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇(017951)申购赎回 |
||||||
|---|---|---|---|---|---|---|
| 报告期 | 期初总份额(份) | 期末总份额(份) | 期间总申购份额(份) | 期间总赎回份额(份) | 期间净申赎份额(份) | 净申赎比例 |
| 2026/3/31 | 472,921 | 509,265 | 105,123 | 68,778 | 36,345 | 7.69% |
| 2025/12/31 | 315,353 | 472,921 | 489,365 | 331,798 | 157,567 | 49.97% |
| 2025/12/31 | 457,293 | 472,921 | 203,805 | 188,177 | 15,628 | 3.42% |
| 2025/9/30 | 330,130 | 457,293 | 194,185 | 67,023 | 127,162 | 38.52% |
| 2025/6/30 | 315,353 | 330,130 | 91,375 | 76,598 | 14,777 | 4.69% |
| 2025/6/30 | 279,006 | 330,130 | 72,787 | 21,663 | 51,124 | 18.32% |
| 2025/3/31 | 315,353 | 279,006 | 18,588 | 54,935 | -36,347 | -11.53% |
| 2024/12/31 | 133,014 | 315,353 | 350,223 | 167,884 | 182,339 | 137.08% |
| 2024/12/31 | 184,153 | 315,353 | 155,822 | 24,621 | 131,201 | 71.25% |
| 2024/9/30 | 182,731 | 184,153 | 23,683 | 22,261 | 1,422 | 0.78% |
| 2024/6/30 | 133,014 | 182,731 | 170,718 | 121,002 | 49,716 | 37.38% |
| 2024/6/30 | 178,578 | 182,731 | 71,754 | 67,601 | 4,153 | 2.33% |
| 2024/3/31 | 133,014 | 178,578 | 98,964 | 53,400 | 45,564 | 34.26% |
| 2023/12/31 | 9,999 | 133,014 | 123,999 | 985 | 123,014 | 1230.23% |
| 2023/12/31 | 30,964 | 133,014 | 102,050 | 0 | 102,050 | 329.58% |
| 2023/9/30 | 10,910 | 30,964 | 20,054 | 0 | 20,054 | 183.8% |
| 2023/6/30 | 9,999 | 10,910 | 1,896 | 985 | 911 | 9.11% |
| 2023/6/30 | 10,984 | 10,910 | 911 | 985 | -74 | -0.67% |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。